Phase4 Partners Overview
- Investor Type
-
Venture Capital
- Status
-
Inactive
- Investments
-
43
- Exits
-
34
Phase4 Partners General Information
Company Description
Phase4 Partners was a venture capital firm that used to invest in the healthcare sector.
Business Details
Website
www.phase4-partners.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- 4th Floor
- Cavendish Place
- London W1G 0QF
- England, United Kingdom
Phase4 Partners Investments (43)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Avocode | 20-Jan-2020 | Later Stage VC | 00000 | Multimedia and Design Software | Generating Revenue | |
| Albireo | 03-Nov-2016 | 00 000000000 | 0000 | Biotechnology | Generating Revenue | |
| Nabriva Therapeutics | 07-Apr-2015 | 00000 00000 | 00000 | Drug Discovery | Generating Revenue/Not Profitable | 000000 00000 |
| ACADIA Pharmaceuticals | 21-Dec-2012 | 0000 | 000.00 | Pharmaceuticals | Generating Revenue/Not Profitable | 00000000 000 |
| Nabriva Therapeutics | 01-Mar-2012 | 00000000000 | Drug Discovery | Generating Revenue/Not Profitable | 000000 00000 | |
| Paratek Pharmaceuticals | 01-Mar-2012 | 00000 00000 | Pharmaceuticals | Generating Revenue/Not Profitable | ||
| Nabriva Therapeutics | 01-Jul-2011 | 00000000000 | Drug Discovery | Generating Revenue/Not Profitable | 000000 00000 | |
| Nabriva Therapeutics | 01-Oct-2010 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue/Not Profitable | 000000 00000 |
| Sequenom | 21-May-2010 | PIPE | 000.00 | Monitoring Equipment | Profitable | |
| Nabriva Therapeutics | 28-Oct-2009 | Early Stage VC | 000.00 | Drug Discovery | Generating Revenue/Not Profitable | 000000 00000 |
Phase4 Partners Exits (34)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Avocode | 01-Dec-2020 | Secondary Transaction - Private | |
| OncoMed Pharmaceuticals | 23-Apr-2019 | 000000000000 | 000.00 |
| Chroma Therapeutics | 01-Aug-2018 | 000 00 00000 | |
| Albireo | 24-May-2017 | 000000 00000 | 000.00 |
| Albireo | 03-Nov-2016 | 0000000 0000 | 000.00 |
| Nabriva Therapeutics | 18-Sep-2015 | 000 | 000.00 |
| Targacept | 20-Aug-2015 | 000000000000 | 000.00 |
| Zosano Pharma | 27-Jan-2015 | 000 | 000.00 |
| Paratek Pharmaceuticals | 30-Oct-2014 | Reverse Merger | 0000 |
| OncoMed Pharmaceuticals | 18-Jul-2013 | IPO | 000.00 |
Phase4 Partners Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Phase4 Partners Co-Investors (2)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Heda Ventures | 1 | 0 |
|
|
|
| Hustle Fund | 0 | 0 |
|
|
Phase4 Partners FAQs
-
What is Phase4 Partners?
Phase4 Partners was a venture capital firm that used to invest in the healthcare sector.
-
When was Phase4 Partners founded?
Phase4 Partners was founded in 1999.
-
Where is Phase4 Partners headquartered?
Phase4 Partners is headquartered in London, United Kingdom.
-
How many investments has Phase4 Partners made?
Phase4 Partners has made 43 investments.
-
What has Phase4 Partners invested in?
Phase4 Partners has made numerous investments in companies like Avocode, Albireo, and Nabriva Therapeutics within the Multimedia and Design Software, Biotechnology, and Drug Discovery industries.
-
What has Phase4 Partners invested in recently?
Phase4 Partners's latest investment was on 20-Jan-2020 in Avocode, a company within the Multimedia and Design Software industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
